Arrowhead Pharmaceuticals, Inc. (ARWR)

NASDAQ: ARWR · Real-Time Price · USD

74.95

-0.59 (-0.78%)

At close: May 22, 2026, 4:00 PM EDT

74.63

-0.32 (-0.43%)

After-hours: May 22, 2026, 7:53 PM EDT

Revenue

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
GSK Revenue	-	2.65M	2.69M
GSK Revenue Growth	-	-1.49%	-90.95%
Takeda Revenue	-	-	866.00K
Takeda Revenue Growth	-	-	-99.47%
Sarepta Revenue	425.30M	696.80M	-
Sarepta Revenue Growth	-38.96%	-	-
Sanofi Revenue	-	130.00M	-
Revenue (Other)	196.71M	-	-
Revenue (Total)	622.01M	829.45M	3.55M
Revenue (Total) Growth	-25.01%	23258.15%	-98.52%

Updated May 7, 2026. Data Source: Fiscal.ai.